Ligand modified nanoparticles increases cell uptake, alters endocytosis and elevates glioma distribution and internalization
Citations Over TimeTop 1% of 2013 papers
Abstract
Nanoparticles (NPs) were widely used in drugs/probes delivery for improved disease diagnosis and/or treatment. Targeted delivery to cancer cells is a highly attractive application of NPs. However, few studies have been performed on the targeting mechanisms of these ligand-modified delivery systems. Additional studies are needed to understand the transport of nanoparticles in the cancer site, the interactions between nanoparticles and cancer cells, the intracellular trafficking of nanoparticles within the cancer cells and the subcellular destiny and potential toxicity. Interleukin 13 (IL-13) peptide can specifically bind IL-13Rα2, a receptor that is highly expressed on glioma cells but is expressed at low levels on other normal cells. It was shown that the nanoparticels modification with the IL-13 peptide could improve glioma treatment by selectively increasing cellular uptake, facilitating cell internalization, altering the uptake pathway and increasing glioma localization.
Related Papers
- → Anchored but not internalized: shape dependent endocytosis of nanodiamond(2017)44 cited
- → Endocytosis and signals for internalization(1991)207 cited
- → The effects of chronic ethanol administration on the rates of internalization of various ligands during hepatic endocytosis(1992)26 cited
- → Multiple pathways for ligand internalization in rat hepatocytes II: Effect of hyperosmolarity and contribution of fluid‐phase endocytosis(1991)21 cited
- Insulin internalization in isolated rat hepatocytes(1990)